NewAmsterdam Pharma Company N.V.

NasdaqGM:NAMS

Location

Market Cap

USD 2.08 B

Share Price

USD 18.57

Avg Daily Volume

921,979

Change (1 day)

0.65%

Change (1 year)

-4.96%

Change (YTD)

-27.74%

NewAmsterdam Pharma Company N.V. Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending March 31, 2025: USD 153.73 M

NewAmsterdam Pharma Company N.V. Research and Development (R&D) Expenses is USD 153.73 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 3.49% change year over year. Research and development (R&D) expenses are the costs associated with the development of new products, technologies, or improvements to existing products.
  • NewAmsterdam Pharma Company N.V. Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 148.54 M, a 36.85% change year over year.
  • NewAmsterdam Pharma Company N.V. Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 108.54 M, a 197.47% change year over year.
  • NewAmsterdam Pharma Company N.V. Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 36.49 M.
Key data
Date Research and Development (R&D) Expenses Revenue Revenue Gross Profit
Market news
Loading...
NasdaqGM: NAMS

NewAmsterdam Pharma Company N.V.

CEO Dr. Michael Harvey Davidson FACC, Facp., M.D.
IPO Date Feb. 9, 2021
Location Netherlands
Headquarters Gooimeer 2-35
Employees 68
Sector 🏥 Health Care
Industries
Description

NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases. Its lead investigational candidate, obicetrapib, is a novel, selective inhibitor that targets the Cholesteryl Ester Transfer Protein (CETP), which has been clinically shown to reduce low-density lipoprotein cholesterol (LDL-C) while at the same time substantially increase high-density lipoprotein cholesterol (HDL-C). The company was founded in 2019 and is based in Naarden, the Netherlands.

Similar companies

ABBV

AbbVie Inc.

USD 182.31

-2.40%

NOVO-B.CO

Novo Nordisk A/S

USD 68.56

1.71%

RO.SW

Roche Holding AG

USD 347.50

0.20%

ABT

Abbott Laboratories

USD 134.38

0.53%

NOVN.SW

Novartis AG

USD 120.31

0.29%

AZN.L

AstraZeneca PLC

USD 140.24

0.73%

MRK

Merck & Co., Inc.

USD 79.10

0.34%

AMGN

Amgen Inc.

USD 277.13

-0.71%

PFE

Pfizer Inc.

USD 24.19

-0.21%

GILD

Gilead Sciences, Inc.

USD 110.67

2.83%

SAN.PA

Sanofi

USD 96.65

0.37%

VRTX

Vertex Pharmaceuticals Incorporated

USD 441.30

-0.47%

BMY

Bristol-Myers Squibb Company

USD 46.35

-0.64%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 51.91

-1.13%

GSK.L

GSK plc

USD 19.28

0.69%

CSL.AX

CSL Limited

USD 153.01

-2.58%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 131.98

1.04%

REGN

Regeneron Pharmaceuticals, Inc.

USD 521.00

0.00%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.24

-0.32%

4502.T

Takeda Pharmaceutical Company Limited

USD 30.16

-0.03%

ALNY

Alnylam Pharmaceuticals, Inc.

USD 322.83

1.44%

UCB.BR

UCB SA

USD 199.41

0.97%

GEHC

GE HealthCare Technologies Inc.

USD 74.38

-0.64%

BAYN.DE

Bayer AG

USD 31.61

2.81%

068270.KS

Celltrion, Inc.

USD 116.73

-0.46%

2359.HK

WuXi AppTec Co., Ltd.

USD 9.68

-1.75%

3692.HK

Hansoh Pharmaceutical Group Company Limited

USD 3.71

-0.01%

LH

Laboratory Corporation of America Holdings

USD 260.59

1.41%

INSM

Insmed Incorporated

USD 99.49

-2.21%

RPRX

Royalty Pharma plc

USD 35.87

1.70%

BIIB

Biogen Inc.

USD 126.08

-0.66%

4503.T

Astellas Pharma Inc.

USD 9.69

0.99%

1801.HK

Innovent Biologics, Inc.

USD 9.85

-1.60%

SMMT

Summit Therapeutics Inc.

USD 20.60

-3.38%

4507.T

Shionogi & Co., Ltd.

USD 17.51

-0.68%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 39.09

3.96%

GMAB.CO

Genmab A/S

USD 205.20

-0.79%

NBIX

Neurocrine Biosciences, Inc.

USD 125.42

-1.02%

EXEL

Exelixis, Inc.

USD 43.67

1.35%

MANKIND.NS

Mankind Pharma Limited

USD 27.30

1.56%

603392.SS

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.56

0.65%

RGC

Regencell Bioscience Holdings Limited

USD 17.40

-13.82%

9926.HK

Akeso, Inc.

USD 11.78

-2.48%

ASND

Ascendis Pharma A/S

USD 172.22

-0.42%

LUPIN.NS

Lupin Limited

USD 22.64

0.60%

BMRN

BioMarin Pharmaceutical Inc.

USD 55.17

1.98%

SOBI.ST

Swedish Orphan Biovitrum AB (publ)

USD 29.88

2.57%

IPN.PA

Ipsen S.A.

USD 120.09

-0.15%

000963.SZ

Huadong Medicine Co., Ltd

USD 5.63

0.53%

StockViz Staff

June 30, 2025

Any question? Send us an email